Log in to save to my catalogue

Second generation androgen receptor antagonists and challenges in prostate cancer treatment

Second generation androgen receptor antagonists and challenges in prostate cancer treatment

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dead0af0f2fa43b59f7c0f0ebdf58075

Second generation androgen receptor antagonists and challenges in prostate cancer treatment

About this item

Full title

Second generation androgen receptor antagonists and challenges in prostate cancer treatment

Publisher

London: Nature Publishing Group UK

Journal title

Cell death & disease, 2022-07, Vol.13 (7), p.632-632, Article 632

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Prostate cancer is a hormone-dependent malignancy, whose onset and progression are closely related to the activity of the androgen receptor (AR) signaling pathway. Due to this critical role of AR signaling in driving prostate cancer, therapy targeting the AR pathway has been the mainstay strategy for metastatic prostate cancer treatment. The utilit...

Alternative Titles

Full title

Second generation androgen receptor antagonists and challenges in prostate cancer treatment

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_dead0af0f2fa43b59f7c0f0ebdf58075

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dead0af0f2fa43b59f7c0f0ebdf58075

Other Identifiers

ISSN

2041-4889

E-ISSN

2041-4889

DOI

10.1038/s41419-022-05084-1

How to access this item